Courtney S Davis

We don’t have enough information about this author to calculate their statistics. If you think this is an error let us know.
Learn More
Canagliflozin-metformin is one of the newest combination therapies available for the treatment of type 2 diabetes mellitus (T2DM). Canagliflozin is an inhibitor of the sodium-glucose co-transporter 2 which causes an increase in the urinary excretion of glucose. In the present article, we review the safety and efficacy of canagliflozin and metformin from(More)
  • 1